141 related articles for article (PubMed ID: 6624137)
1. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.
Teunissen MW; Joeres RP; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137
[TBL] [Abstract][Full Text] [Related]
2. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
Danhof M; Krom DP; Breimer DD
Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
[TBL] [Abstract][Full Text] [Related]
3. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
Groen K; Breimer DD; van Bezooijen CF
Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725
[TBL] [Abstract][Full Text] [Related]
5. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver.
Kahn GC; Boobis AR; Murray S; Davies DS
Xenobiotica; 1982 Aug; 12(8):509-16. PubMed ID: 7147996
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cytochrome P-448 mixed function oxidase activity following administration of 9-hydroxyellipticine to rats.
Delaforge M; Ioannides C; Parke DV
Chem Biol Interact; 1980 Oct; 32(1-2):101-10. PubMed ID: 7428105
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of antipyrine and m-xylene in rats after prolonged pretreatment with xylene alone or xylene with ethanol, phenobarbital or 3-methylcholanthrene.
Elovaara E; Engström K; Häyri L; Hase T; Aitio A
Xenobiotica; 1989 Sep; 19(9):945-60. PubMed ID: 2815836
[TBL] [Abstract][Full Text] [Related]
9. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking.
Spoelstra P; Teunissen MW; Janssens AR; Weeda B; van Duijn W; Koch CW; Breimer DD
Eur J Clin Invest; 1986 Aug; 16(4):321-7. PubMed ID: 3093244
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of norantipyrine sulphate and norantipyrine glucuronide as major metabolites of antipyrine in man and rat.
Böttcher J; Bässmann H; Schüppel R
J Pharm Pharmacol; 1984 Jun; 36(6):391-8. PubMed ID: 6146671
[TBL] [Abstract][Full Text] [Related]
11. Antipyrine clearance and metabolism in patients with psoriasis.
Kubota K; Ishizaki T; Chiba K; Takagi A; Nakagawa A; Nakamura K
Br J Clin Pharmacol; 1986 Oct; 22(4):455-62. PubMed ID: 3768257
[TBL] [Abstract][Full Text] [Related]
12. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
Teunissen MW; Kampf D; Roots I; Vermeulen NP; Breimer DD
Eur J Clin Pharmacol; 1985; 28(5):589-95. PubMed ID: 4043202
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of the safrole-induced mixed-function oxidase activities by 9-hydroxyellipticine.
Delaforge M; Ioannides C; Parke DV
Chem Biol Interact; 1982 Dec; 42(3):279-89. PubMed ID: 7151231
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of metronidazole and antipyrine in isolated rat hepatocytes. Influence of sex and enzyme induction and inhibition.
Loft S; Poulsen HE
Biochem Pharmacol; 1989 Apr; 38(7):1125-36. PubMed ID: 2706012
[TBL] [Abstract][Full Text] [Related]
15. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
Loft S; Nielsen AJ; Borg BE; Poulsen HE
Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
[TBL] [Abstract][Full Text] [Related]
16. Effect of age on the pharmacokinetics of antipyrine in calves.
Janus K; Suszycka J
Res Vet Sci; 1996 May; 60(3):234-7. PubMed ID: 8735513
[TBL] [Abstract][Full Text] [Related]
17. Correlation between in vivo antipyrine metabolite formation and theophylline metabolism in rats.
Teunissen MW; Brorens IO; De Langen HJ; Geerlings AM; Breimer DD
Pharm Res; 1986 Jun; 3(3):156-61. PubMed ID: 24271521
[TBL] [Abstract][Full Text] [Related]
18. The effect of age on the oxidative metabolism of antipyrine by uninduced microsomal fractions of rat liver.
Van Geel CA; Van Bezooijen CF
Mech Ageing Dev; 1990 Apr; 53(2):169-77. PubMed ID: 2342384
[TBL] [Abstract][Full Text] [Related]
19. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
20. Influence of cigarette smoke on antipyrine metabolite formation in rats.
Nakagawa A; Chiba K; Ishizaki T; Nakamura K
Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):473-91. PubMed ID: 6635330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
